Micardis® in Patients With Essential Hypertension

• Status: Completed
• Trial end date: 1969-12-31

Summary

The aim of this observational study was to supplement the data on efficacy, safety, and tolerability of telmisartan under daily conditions in hospitals

Details

• Lead Sponsor: Boehringer Ingelheim
• Treatments: Telmisartan